Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 4223

Kelun's $250M PIPE; Valneva moves chikungunya vaccine to Phase 3 for kids

$
0
0
Plus, news about Trevi Therapeutics: Kelun Biotech’s $250M stock sale: The Sichuan company upsized its PIPE from $200 to $250 million and included investors from around the globe, including sovereign wealth funds and healthcare specialist ...

Viewing all articles
Browse latest Browse all 4223

Latest Images

Trending Articles



Latest Images